BioCorRx Inc. (BICX)

[cayman_west]

Fresh Start Private Naltrexone Implant Receives Approval From BlueCross BlueShield for Claims for Its Alcohol Treatment Day-Procedure

25% of All Fresh Start Private Claims Being Processed Through BlueCross BlueShield

LOS ANGELES, CA--(Marketwire - Apr 25, 2011) - Fresh Start Private (OTCBB: CEYY), a leader in the alcohol treatment and rehabilitation industry, announced that its alcohol treatment procedure has received approval from BlueCross BlueShield for the approval of its alcohol treatment program.

The terms include commitment for prompt payment from BlueCross BlueShield.

Alcohol problems affect employees in industries from manufacturing to information technology, from the boardroom to the shop floor. Alcohol costs American employers an estimated $134 billion in productivity losses, mostly due to missed work. With a relatively small investment in effective prevention and treatment for alcohol problems, employers can reduce costs and help employees.

A Company spokesperson commented, "The wonderful thing about our procedure is it is done in about 20 minutes and patients can go back to work the following day. With any minor surgery there is some swelling, and we monitor our clients with follow up visits with our doctors. The remarkable thing is that our clients are in and out quickly, without the stigma attached to being away from their loved ones for an extended period."

About Fresh Start Private

Fresh Start Private is an alcohol addiction, alcohol withdrawal, alcohol abuse treatment and alcohol detox rehabilitation company on the leading edge of the alcohol addiction treatment. The Company has licensed a highly effective treatment that delivers target therapeutic levels of Naltrexone to significantly reduce patients' cravings for alcohol.

Please visit www.freshstartprivate.com